Literature DB >> 4549965

Binding of 3H-naloxone in the mouse brain: effect of ions and tolerance development.

R J Hitzemann, B A Hitzemann, H H Loh.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4549965     DOI: 10.1016/0024-3205(74)90135-0

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


× No keyword cloud information.
  7 in total

1.  Long-term morphine treatment decreases the association of mu-opioid receptor (MOR1) mRNA with polysomes through miRNA23b.

Authors:  Qifang Wu; Lei Zhang; Ping-Yee Law; Li-Na Wei; Horace H Loh
Journal:  Mol Pharmacol       Date:  2009-01-14       Impact factor: 4.436

2.  The opiate receptors.

Authors:  E J Simon
Journal:  Neurochem Res       Date:  1976-02       Impact factor: 3.996

3.  Supersensitivity to opioids following the chronic blockade of endorphin action by naloxone.

Authors:  R Schulz; M Wüster; A Herz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-01       Impact factor: 3.000

4.  Interaction of calcium with 3H-morphine binding to synaptosomes of the guinea-pig ileum.

Authors:  F A Opmeer; A Witter; J M van Ree
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-10       Impact factor: 3.000

5.  Visualization of opiate receptor upregulation by light microscopy autoradiography.

Authors:  A Tempel; E L Gardner; R S Zukin
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

6.  A role for mu opioid receptors in cocaine-induced activity, sensitization, and reward in the rat.

Authors:  Joseph A Schroeder; Michele Hummel; Alpha D Simpson; Rizwan Sheikh; Avery R Soderman; Ellen M Unterwald
Journal:  Psychopharmacology (Berl)       Date:  2007-08-09       Impact factor: 4.530

7.  The interaction of the mu-opioid receptor and G protein is altered after chronic morphine treatment in rats.

Authors:  P L Tao; C R Lee; P Y Law; H H Loh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-11       Impact factor: 3.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.